Xavier DURANDO, Pr
Centre Jean Perrin
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xavier DURANDO, Pr as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:59 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05157594 · hPG80 (Circulating Progastrin) as a Blood Biomarker for High-grade Glial TumorsCentre Jean Perrin · completed · Glial Cell Tumors · principal investigator
- N/ANCT04068623 · Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer PatientsCentre Jean Perrin · active not recruiting · Triple Negative Breast Cancer · principal investigator
- Ph3NCT02454855 · Impact of a Melatonin Supplementation on the Quality of Life in Elderly Metastatic Cancer PatientsCentre Jean Perrin · terminated · Cancer · principal investigator
- Ph1/Ph2NCT02364206 · Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed GlioblastomaCentre Jean Perrin · completed · Adult Glioblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.